|
|
||||||||
1 Departments of Metabolic Diseases and Internal Medicine, University of Padova, 35128 Padua; and 2 Department of Nephrology and Internal Medicine, University of Genova, 16132 Genoa, Italy
Overt nephrotic syndrome is characterized by albumin and fibrinogen hyperproduction and reduced very low density lipoprotein apolipoprotein B-100 (VLDL apoB-100) clearance. Whether similar changes also occur in low-grade proteinuria is not known. Thus we measured albumin, fibrinogen, and VLDL apoB-100 kinetics in six patients with modest proteinuria and normal creatinine clearance (P) and in ten control subjects (C) by leucine tracer infusion and precursor-product relationships. In P, plasma albumin concentration was decreased (P < 0.003), whereas concentrations of fibrinogen and VLDL apoB-100 were increased (P < 0.001). In P, albumin fractional secretion rate (FSR) was increased (P < 0.01), fibrinogen FSR was normal, and VLDL apoB-100 FSR was decreased (P < 0.03). As a result, in P, absolute secretion rates (ASR) of albumin and fibrinogen were increased (P < 0.03), whereas VLDL apoB-100 ASR was normal. Albumin FSR was inversely correlated to oncotic pressure in P but not in C. These findings suggest that low-grade nephrotic proteinuria is characterized by simultaneous multiple alterations in turnover rates of albumin, fibrinogen, and VLDL apoB-100. Their pathogenesis, however, appears to be multifactorial.
nephrotic syndrome; very low density lipoprotein apolipoprotein B-100; albumin; fibrinogen; protein synthesis
This article has been cited by other articles:
![]() |
J. E. H. Bunt, T. Rietveld, H. Schierbeek, J. L. D. Wattimena, L. J. I. Zimmermann, and J. B. van Goudoever Albumin synthesis in preterm infants on the first day of life studied with [1-13C]leucine Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1157 - G1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. H. M. van den Wijngaard, A. Umur, R. T. Krediet, M. G. Ross, and M. J. C. van Gemert Modeling a hydropic recipient twin in twin-twin transfusion syndrome Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R799 - R814. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |